What's breaking now, across thousands of outlets.
At least 50 different venture investors have benefited from Eli Lilly’s dealmaking this year, sending early investment dollars back into the startup ecosystem. On Monday, Lilly announced its 13th acquisition of the year, up to ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The way cancer-causing proteins accumulate in tumors may influence how effectively a promising new generation of medicines can remove them, a study suggests.
Father Henry J. Denis emerged from the horrors of Dachau concentration camp and the inhumane medical experiments conducted there.
Here are some of the key questions about the agreements the Trump administration has reached with drugmakers on pricing.
Coming near the start of the fourth day of deliberations, this was the first time the jury gave any indication they were at an impasse.
The Democratic Republic of Congo has recorded more than 6,000 confirmed cases and nearly 3,000 deaths from the country’s worst Ebola epidemic ever, according to the Congolese authorities’ latest toll…
Though Alumis still sees a path forward in lupus, the result made its drug the latest TYK2 blocker to struggle in conditions beyond psoriasis and psoriatic arthritis.
